Cargando…
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
BACKGROUND: In B-cell precursor acute lymphoblastic leukaemia (B-ALL), the identification of additional genetic alterations associated with poor prognosis is still of importance. We determined the frequency and prognostic impact of somatic mutations in children and adult cases with B-ALL treated wit...
Autores principales: | Forero-Castro, Maribel, Robledo, Cristina, Benito, Rocío, Bodega-Mayor, Irene, Rapado, Inmaculada, Hernández-Sánchez, María, Abáigar, María, Maria Hernández-Sánchez, Jesús, Quijada-Álamo, Miguel, María Sánchez-Pina, José, Sala-Valdés, Mónica, Araujo-Silva, Fernanda, Kohlmann, Alexander, Luis Fuster, José, Arefi, Maryam, de las Heras, Natalia, Riesco, Susana, Rodríguez, Juan N, Hermosín, Lourdes, Ribera, Jordi, Camos Guijosa, Mireia, Ramírez, Manuel, de Heredia Rubio, Cristina Díaz, Barragán, Eva, Martínez, Joaquín, Ribera, José M, Fernández-Ruiz, Elena, Hernández-Rivas, Jesús-María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520505/ https://www.ncbi.nlm.nih.gov/pubmed/28557976 http://dx.doi.org/10.1038/bjc.2017.152 |
Ejemplares similares
-
Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome
por: Forero-Castro, Maribel, et al.
Publicado: (2016) -
Integrated Genomic Analysis of Chromosomal Alterations and Mutations in B-Cell Acute Lymphoblastic Leukemia Reveals Distinct Genetic Profiles at Relapse
por: Forero-Castro, Maribel, et al.
Publicado: (2020) -
Identification of expression patterns in the progression of disease stages by integration of transcriptomic data
por: Aibar, Sara, et al.
Publicado: (2016) -
Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia
por: Quijada-Álamo, Miguel, et al.
Publicado: (2017) -
The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia
por: García-Tuñón, Ignacio, et al.
Publicado: (2017)